Publication | Closed Access
Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
137
Citations
46
References
2008
Year
Although additional studies are required for confirmation, our findings could optimize the use of cetuximab in MCRC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1